Science & Research

One psilocybin session and fewer days of cocaine use: a randomized trial

JAMA Network Open · 2026

One psilocybin session and fewer days of cocaine use: a randomized trial

Photo: Casey Horner on Unsplash

The question

There is no approved medicine for cocaine use disorder. Researchers at the University of Alabama at Birmingham asked whether a single psilocybin session, combined with talk therapy, could help people use cocaine less.

Who took part and what happened

The study was a randomized, placebo-controlled trial (people were assigned to groups by chance). 40 adults with cocaine use disorder were split into two groups of 20.

  • One group received a single dose of psilocybin (25 mg per 70 kg of body weight).
  • The other received 100 mg of diphenhydramine, an antihistamine used as an active placebo.

Neither the participants nor the staff knew who got what. Everyone received the same structured psychotherapy before and after the session. People were followed for 180 days.

What they found

  • The psilocybin group had more cocaine-free days. On average the difference was about 29 percentage points.
  • 6 of 20 people (30%) in the psilocybin group did not use cocaine at all from the integration period through day 180. In the placebo group, none did (0 of 20).
  • At 90 days, an estimated 55% of the psilocybin group had not had a first lapse, compared with 21% of the placebo group.
  • No serious treatment-related side effects were reported.

What this study does not tell us

The study was small and took place at a single centre. Most participants were Black men with low incomes, so the results may not apply to everyone. Most people in the psilocybin group correctly guessed their group, which can strengthen expectations. The psilocybin group also spent more days in integration therapy. Larger trials are needed.

Why it matters

This is one of the first placebo-controlled trials of psilocybin for cocaine use disorder. The effect lasted for six months after a single session, which is encouraging for a condition with few options.

This is a summary of published research for general information. It is not medical advice. The study took place in a clinical research setting with medical screening and professional support.

Source: Hendricks PS, Lappan SN, Shelton RC, Lahti AC, Cropsey KL, Johnson MW, et al. (2026). Psilocybin in the Treatment of Cocaine Use Disorder: A Randomized Clinical Trial. JAMA Network Open, 9(5), e2611029. doi:10.1001/jamanetworkopen.2026.11029 · PubMed · Full text

More research

All research → · About MycoSpirit · Health & Safety

Made on
Tilda